234 related articles for article (PubMed ID: 21447966)
1. Clinical impact of pregnancy in mastocytosis: a study of the Spanish Network on Mastocytosis (REMA) in 45 cases.
Matito A; Álvarez-Twose I; Morgado JM; Sánchez-Muñoz L; Orfao A; Escribano L
Int Arch Allergy Immunol; 2011; 156(1):104-11. PubMed ID: 21447966
[TBL] [Abstract][Full Text] [Related]
2. Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.
Alvarez-Twose I; Zanotti R; González-de-Olano D; Bonadonna P; Vega A; Matito A; Sánchez-Muñoz L; Morgado JM; Perbellini O; García-Montero A; De Matteis G; Teodósio C; Rossini M; Jara-Acevedo M; Schena D; Mayado A; Zamò A; Mollejo M; Sánchez-López P; Cabañes N; Orfao A; Escribano L; ;
J Allergy Clin Immunol; 2014 Feb; 133(2):520-8. PubMed ID: 23921094
[TBL] [Abstract][Full Text] [Related]
3. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
4. Validation of the REMA score for predicting mast cell clonality and systemic mastocytosis in patients with systemic mast cell activation symptoms.
Alvarez-Twose I; González-de-Olano D; Sánchez-Muñoz L; Matito A; Jara-Acevedo M; Teodosio C; García-Montero A; Morgado JM; Orfao A; Escribano L
Int Arch Allergy Immunol; 2012; 157(3):275-80. PubMed ID: 22042301
[TBL] [Abstract][Full Text] [Related]
5. Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes.
Florian S; Krauth MT; Simonitsch-Klupp I; Sperr WR; Fritsche-Polanz R; Sonneck K; Födinger M; Agis H; Böhm A; Wimazal F; Horny HP; Valent P
Int Arch Allergy Immunol; 2005 Mar; 136(3):273-80. PubMed ID: 15722637
[TBL] [Abstract][Full Text] [Related]
6. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients.
Brockow K; Jofer C; Behrendt H; Ring J
Allergy; 2008 Feb; 63(2):226-32. PubMed ID: 18186813
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy and Delivery in Patients with Mastocytosis Treated at the Polish Center of the European Competence Network on Mastocytosis (ECNM).
Ciach K; Niedoszytko M; Abacjew-Chmylko A; Pabin I; Adamski P; Leszczynska K; Preis K; Olszewska H; Wydra DG; Hansdorfer-Korzon R
PLoS One; 2016; 11(1):e0146924. PubMed ID: 26796887
[TBL] [Abstract][Full Text] [Related]
8. Management of Anesthesia in Adult and Pediatric Mastocytosis: A Study of the Spanish Network on Mastocytosis (REMA) Based on 726 Anesthetic Procedures.
Matito A; Morgado JM; Sánchez-López P; Álvarez-Twose I; Sánchez-Muñoz L; Orfao A; Escribano L
Int Arch Allergy Immunol; 2015; 167(1):47-56. PubMed ID: 26160029
[TBL] [Abstract][Full Text] [Related]
9. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.
Alvarez-Twose I; González de Olano D; Sánchez-Muñoz L; Matito A; Esteban-López MI; Vega A; Mateo MB; Alonso Díaz de Durana MD; de la Hoz B; Del Pozo Gil MD; Caballero T; Rosado A; Sánchez Matas I; Teodósio C; Jara-Acevedo M; Mollejo M; García-Montero A; Orfao A; Escribano L
J Allergy Clin Immunol; 2010 Jun; 125(6):1269-1278.e2. PubMed ID: 20434205
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.
Valent P; Sperr WR; Schwartz LB; Horny HP
J Allergy Clin Immunol; 2004 Jul; 114(1):3-11; quiz 12. PubMed ID: 15241337
[TBL] [Abstract][Full Text] [Related]
11. Severe life-threatening or disabling anaphylaxis in patients with systemic mastocytosis: a single-center experience.
Wimazal F; Geissler P; Shnawa P; Sperr WR; Valent P
Int Arch Allergy Immunol; 2012; 157(4):399-405. PubMed ID: 22123213
[TBL] [Abstract][Full Text] [Related]
12. Mastocytosis - an update.
Amon U; Hartmann K; Horny HP; Nowak A
J Dtsch Dermatol Ges; 2010 Sep; 8(9):695-711; quiz 712. PubMed ID: 20678151
[TBL] [Abstract][Full Text] [Related]
13. Mastocytosis: a rare case of anaphylaxis in paediatric age and literature review.
Silva I; Carvalho S; Pinto PL; Machado S; Rosado Pinto J
Allergol Immunopathol (Madr); 2008; 36(3):154-63. PubMed ID: 18680704
[TBL] [Abstract][Full Text] [Related]
14. Anesthesia in children with mastocytosis--a case based review.
Ahmad N; Evans P; Lloyd-Thomas AR
Paediatr Anaesth; 2009 Feb; 19(2):97-107. PubMed ID: 19207896
[TBL] [Abstract][Full Text] [Related]
15. Mast cells and mastocytosis.
Söderholm JD
Dig Dis; 2009; 27 Suppl 1():129-36. PubMed ID: 20203509
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of lirentelimab in patients with refractory indolent systemic mastocytosis: a first-in-human clinical trial.
Siebenhaar F; Altrichter S; Bonnekoh H; Hawro T; Hawro M; Michaelis EG; Kantor AM; Chang AT; Youngblood BA; Singh B; Rasmussen HS; Maurer M
Br J Dermatol; 2023 Oct; 189(5):511-519. PubMed ID: 37290787
[TBL] [Abstract][Full Text] [Related]
17. [Mastocytosis, classification, biological diagnosis and therapy].
Arock M
Ann Biol Clin (Paris); 2004; 62(6):657-69. PubMed ID: 15563424
[TBL] [Abstract][Full Text] [Related]
18. Use of a doula for labor coaching in a patient with indolent systemic mastocytosis in pregnancy.
Kehoe SL; Bathgate SL; Macri CJ
Obstet Gynecol; 2006 Feb; 107(2 Pt 2):514-6. PubMed ID: 16449169
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of the mastocytosis quality of life questionnaire: MC-QoL.
Siebenhaar F; von Tschirnhaus E; Hartmann K; Rabenhorst A; Staubach P; Peveling-Oberhag A; Wagner N; Martus P; Carter MC; Metcalfe DD; Church MK; Maurer M; Weller K
Allergy; 2016 Jun; 71(6):869-77. PubMed ID: 26797792
[TBL] [Abstract][Full Text] [Related]
20. Pediatric cutaneous mastocytosis: a review of 180 patients.
Ben-Amitai D; Metzker A; Cohen HA
Isr Med Assoc J; 2005 May; 7(5):320-2. PubMed ID: 15909466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]